RVP trade ideas
RVP longalready put my analysis on the chart drawings
vaccines rolling out, I'm bullish because we need 100000000 syringes
plus my entry makes my risk proposition super low - risk 1 to make 4, i'll take that any day
Even if price doesnt hit 20$, I'm still risking 1 to make 2 or 3 which I'll be pretty damn happy with in less than 1 month
just a trade idea i found and no real idea what company does and i don't generally like to swing health care stocks so played this as a small position
RVP - meme stock, hype stockI don't know much about this company except that it landed on my radar from hearing about it.
Based on the parabolic move that happened since March when it was trading at around 1$, this thing has made like 1400% and pulled back.
A break out above 14$ will send this stock flying. Otherwise right now its trading within a triangle/ascending wedge so don't get faked out and let the price action test the boundaries of this trade set up to enter
I'll personally go in with a buy-stop order at 14.50 on good volume and set a stop loss just under. When these meme cheapy stocks fly, they can fly 50% to 100% in a matter of weeks. No one gives a crap about valuation on these unknown companies usually.
RVP Aroon Indicator entered an Uptrend on July 28, 2020Over the last three days, I have detected that RVP's AroonUp green line is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. I backtested this indicator and found 193 similar cases, 184 of which were successful. Based on this data, the odds of success are 90%.
RVP was a top gainer, rising+306.14%.Expect Uptrend continuationRetractable Technologies (RVP, $11.25) was one of top quarterly gainers, jumping +306.14% to $11.25 per share. Tickeron A.I.dvisor analyzed 204 stocks in the Medical Specialties Industry over the last three months, and discovered that 153 of them (74.81%) charted an Uptrend while 51 of them (25.19%) trended down.Tickeron A.I.dvisor found 308 similar cases when RVP's price jumped over 15% within three months. In 167 out of those 308 cases, RVP's price went up during the following month. Based on these historical data,Tickeron A.I. thinks the odds of an Uptrend continuation for RVP are 54%.
RVP's Aroon indicator reaches into Uptrend on July 28, 2020
For traders, this could mean going long on the ticker or exploring call options in the next month. Tickeron AI shows that
in 184 of 193 cases where RVP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Current price $10.67 is above $7.73 the highest resistance line found by TickeronA.I. Throughout the month of 06/24/20 - 07/27/20, the price experienced a +49% Uptrend. During the week of 07/20/20 - 07/27/20, the stock enjoyed a +13% Uptrend growth.
Bullish Trend Analysis
The Momentum Indicator exceeded the 0 level on July 07, 2020. Traders may consider buying the ticker or exploring call options. Tickeron AI shows that
in 89 of 111 cases where the ticker's Momentum Indicator exceeded 0, its price rose further within the subsequent month. The odds of a continued Uptrend are 80%.
RVP soars +187.96%, a 3-month high. Expect Uptrend continuationRetractable Technologies (RVP, $8.61) gained +187.96% and reached a new high over the last three months. By comparison, the broader Medical Specialties Industry returned 34.06% over the same period of time. Tickeron A.I.dvisor analyzed 204 stocks in the Medical Specialties Industry over the same period of time and found that 172 of them (84.33%) were in an Uptrend while 32 of them (15.67%) showed a Downtrend. Tickeron A.I.dvisor found 300 similar cases when RVP's price went up 15% within three months. In 159 out of those 300 cases, RVP's price went up during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend continuation for RVP are 53%.
RVP's Aroon indicator reaches into Uptrend on July 17, 2020
For traders, this could mean going long on the ticker or exploring call options in the next month. Tickeron AI shows that in 177 of 186 cases where RVP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Current price $9.08 is above $5.81 the highest support line found by Tickeron A.I. Throughout the month of 06/15/20 - 07/16/20, the price experienced a +36% Uptrend. During the week of 07/09/20 - 07/16/20, the stock enjoyed a +22% Uptrend growth.
$53.6 million in U.S. government funding Effective July 1, 2020, Retractable Technologies, Inc. (“RTI”) entered into a Technology Investment Agreement (“TIA”) with United States Government Department of Defense, U.S. Army Contracting Command-Aberdeen Proving Ground, Natick Contracting Division & Edgewood Contracting Division (ACC-APG, NCD & ECD) on behalf of the Biomedical Advanced Research and Development Authority (BARDA) (“Government”) for $53,664,286.00 in Government funding to RTI for expanding domestic production of needles and syringes.
The principal purpose of the TIA is for Government investment to fund increasing RTI’s manufacturing capacity for hypodermic safety needles and corresponding syringes in response to the worldwide COVID-19 global pandemic. The Government award is an expenditure type TIA whereby the Government will make payments to RTI for expenditures for equipment and supplies made by RTI in carrying out the purpose of the expansion of RTI’s domestic production. RTI’s contributions under the terms of the TIA to enhance domestic capacity of pandemic essential technology include providing facilities, technical expertise, labor and maintenance of the TIA funded equipment for a 10 year term.
What happened
Retractable Technologies (NYSEMKT:RVP) shares are soaring 22% at 3:55 pm EST on Wednesday after announcing $53.6 million in U.S. government funding to increase syringe and needle manufacturing capacity to meet potential demand related to the COVID-19 coronavirus.
So what
The healthcare company, which manufacturers syringes and needles designed to improve patient safety, was awarded the contract on behalf of the Biomedical Advanced Research and Development Authority (BARDA). In exchange for the funding, Retractable Technologies will "increase its manufacturing capacity for hypodermic safety needles and corresponding syringes."
The U.S. government payments will be used to buy equipment and supplies necessary to ramp production, and the company has agreed to provide facilities, expertise, labor, and maintenance for equipment bought through this agreement for 10 years.
Previously, Retractable Technologies reported in May that future results "may be materially affected" by a $83.8 million order for automated retraction safety syringes from the U.S. Department of Health and Human Services on May 1. Management anticipates fulfilling this order during 2020 and 2021.
Now what
Needles and syringes are essential to patient diagnosis and treatment, and COVID-19's rapid spread has revealed capacity gaps that the U.S. government is attempting to fill via financing agreements like this one.
Retractable Technologies didn't disclose a timeline for this new funding, so investors will want to pay particular attention to its next quarterly update for insight. Nevertheless, these agreements are significant given Retractable Technologies revenue was just $11.2 million in the first quarter of 2020, up from $7.9 million in the same quarter last year.
Since the company's already profitable, with first-quarter net income of $322,773, up from a loss of $129,211 one year ago, this company is worth watching.
RVP was a top gainer,rising +442.61%.Expect Uptrend continuationRetractable Technologies (RVP, $6.24) was one of top quarterly gainers, jumping +442.61% to $6.24 per share. Tickeron A.I.dvisor analyzed 203 stocks in the Medical Specialties Industry over the last three months, and discovered that 191 of them (93.98%) charted an Uptrend while 12 of them (6.02%) trended down. Tickeron A.I.dvisor found 295 similar cases when RVP's price jumped over 15% within three months. In 154 out of those 295 cases, RVP's price went up during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend continuation for RVP are 52%.
$RVP Trend Holding Well Longs Looking GoodRetractable Technologies, Inc. manufactures and markets safety needle devices for the healthcare industry. Its products are designed to protect healthcare workers, patients, and others from needlestick injuries, cross-contamination through reuse, and reduce disposal costs. Its products include VanishPoint and Patient Safe Syringes, EasyPoint Needles, VanishPoint Blood Collection Sets and Tube Holders, VanishPoint IV Catheters. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.
SHORT INTEREST
68.9K 09/30/19
P/E Current
-18.69
P/E Ratio (with extraordinary items)
-58.40
RVP - Bullish Trend Continued Optimism Retractable Technologies, Inc. manufactures and markets safety needle devices for the healthcare industry. Its products are designed to protect healthcare workers, patients, and others from needlestick injuries, cross-contamination through reuse, and reduce disposal costs. Its products include VanishPoint and Patient Safe Syringes, EasyPoint Needles, VanishPoint Blood Collection Sets and Tube Holders, VanishPoint IV Catheters. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.
SHORT INTEREST
142.27K 08/15/19
P/E Current
-12.89
P/E Ratio (with extraordinary items)
-40.28
Retractable Technologies Inc.According to market research “Global Hypodermic Needle Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Type (Safety Needles, Non-Safety Needles), by End User (Hospital, Diagnostic Center, Others)” by P&S Market Research, the global hypodermic needles market is expected to grow at a CAGR of 7.4% during 2016 – 2022.